Literature DB >> 33438180

Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk: 2021 update.

Claudio Borghi1, Justyna Domienik-Karłowicz2,3, Andrzej Tykarski4, Krystyna Widecka5, Krzysztof J Filipiak6, Miłosz J Jaguszewski7, Krzysztof Narkiewicz8, Giuseppe Mancia9.   

Abstract

Entities:  

Year:  2021        PMID： 33438180      PMCID： PMC8105060          DOI： 10.5603/CJ.a2021.0001

Source DB:  PubMed          Journal:  Cardiol J        ISSN： 1898-018X            Impact factor:   2.737


× No keyword cloud information.
  119 in total

Review 1.  Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk.

Authors:  Claudio Borghi; Andrzej Tykarski; Krystyna Widecka; Krzysztof J Filipiak; Justyna Domienik-Karłowicz; Katarzyna Kostka-Jeziorny; Albert Varga; Milosz Jaguszewski; Krzysztof Narkiewicz; Giuseppe Mancia
Journal:  Cardiol J       Date:  2018       Impact factor: 2.737

Review 2.  Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome.

Authors:  Takahiko Nakagawa; Katherine R Tuttle; Robert A Short; Richard J Johnson
Journal:  Nat Clin Pract Nephrol       Date:  2005-12

3.  Febuxostat compared with allopurinol in patients with hyperuricemia and gout.

Authors:  Michael A Becker; H Ralph Schumacher; Robert L Wortmann; Patricia A MacDonald; Denise Eustace; William A Palo; Janet Streit; Nancy Joseph-Ridge
Journal:  N Engl J Med       Date:  2005-12-08       Impact factor: 91.245

4.  Chronic obstructive pulmonary disease (COPD) is associated with a higher level of serum uric acid. A systematic review and meta-analysis.

Authors:  Phuuwadith Wattanachayakul; Pongprueth Rujirachun; Nipith Charoenngam; Patompong Ungprasert
Journal:  Adv Respir Med       Date:  2020

Review 5.  Genetic factors associated with gout and hyperuricemia.

Authors:  Anthony J Bleyer; Thomas C Hart
Journal:  Adv Chronic Kidney Dis       Date:  2006-04       Impact factor: 3.620

Review 6.  Change gout: how to deal with this "silently-developing killer" in everyday clinical practice.

Authors:  Carlo Alberto Scirè; Cristina Rossi; Leonardo Punzi; Augusto Genderini; Claudio Borghi; Walter Grassi
Journal:  Curr Med Res Opin       Date:  2018-04-12       Impact factor: 2.580

7.  Overweight modifies the longitudinal association between uric acid and some components of the metabolic syndrome: The Tromsø Study.

Authors:  Jon V Norvik; Hilde M Storhaug; Kirsti Ytrehus; Trond G Jenssen; Svetlana N Zykova; Bjørn O Eriksen; Marit D Solbu
Journal:  BMC Cardiovasc Disord       Date:  2016-05-10       Impact factor: 2.298

8.  Cross-sectional study of associations between normal body weight with central obesity and hyperuricemia in Japan.

Authors:  Takako Shirasawa; Hirotaka Ochiai; Takahiko Yoshimoto; Satsue Nagahama; Akihiro Watanabe; Reika Yoshida; Akatsuki Kokaze
Journal:  BMC Endocr Disord       Date:  2020-01-06       Impact factor: 2.763

9.  Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study.

Authors:  Edoardo Casiglia; Valérie Tikhonoff; Agostino Virdis; Stefano Masi; Carlo M Barbagallo; Michele Bombelli; Bernardino Bruno; Arrigo F G Cicero; Massimo Cirillo; Pietro Cirillo; Giovambattista Desideri; Lanfranco D'Elia; Claudio Ferri; Ferruccio Galletti; Loreto Gesualdo; Cristina Giannattasio; Guido Iaccarino; Luciano Lippa; Francesca Mallamaci; Alessandro Maloberti; Alberto Mazza; Maria Lorenza Muiesan; Pietro Nazzaro; Paolo Palatini; Gianfranco Parati; Roberto Pontremoli; Fosca Quarti-Trevano; Marcello Rattazzi; Giulia Rivasi; Massimo Salvetti; Giuliano Tocci; Andrea Ungar; Paolo Verdecchia; Francesca Viazzi; Massimo Volpe; Guido Grassi; Claudio Borghi
Journal:  J Hypertens       Date:  2020-03       Impact factor: 4.776

10.  Mutations in the SLC2A9 gene cause hyperuricosuria and hyperuricemia in the dog.

Authors:  Danika Bannasch; Noa Safra; Amy Young; Nili Karmi; R S Schaible; G V Ling
Journal:  PLoS Genet       Date:  2008-11-07       Impact factor: 5.917
View more
  10 in total

1.  The Impact of an Elevated Uric Acid Level on the Prevalence of Coronary Artery Disease in Pancreas Transplant Candidates with Type 1 Diabetes: A Cross Sectional Study.

Authors:  Małgorzata Buksińska-Lisik; Przemysław Kwasiborski; Robert Ryczek; Wojciech Lisik; Artur Mamcarz
Journal:  J Clin Med       Date:  2022-04-26       Impact factor: 4.964

2.  Hyperuricemia as a Marker of Reduced Left Ventricular Ejection Fraction in Patients with Atrial Fibrillation: Results of the POL-AF Registry Study.

Authors:  Marcin Wełnicki; Iwona Gorczyca; Wiktor Wójcik; Olga Jelonek; Małgorzata Maciorowska; Beata Uziębło-Życzkowska; Maciej Wójcik; Robert Błaszczyk; Renata Rajtar-Salwa; Tomasz Tokarek; Jacek Bil; Michał Wojewódzki; Anna Szpotowicz; Małgorzata Krzciuk; Monika Gawałko; Agnieszka Kapłon-Cieślicka; Anna Tomaszuk-Kazberuk; Anna Szyszkowska; Janusz Bednarski; Elwira Bakuła-Ostalska; Beata Wożakowska-Kapłon; Artur Mamcarz
Journal:  J Clin Med       Date:  2021-04-22       Impact factor: 4.241

3.  A multiethnic association analysis of hyperuricaemia with cardiovascular risk in rural and urban areas in Chinese adults.

Authors:  Leilei Liu; Juan Lei; Linyuan Zhang; Nana Ma; Zixuan Xu; Lian Peng; Chan Nie; Jianqin Zhong; Xiao Zhang; Feng Hong
Journal:  Sci Rep       Date:  2021-12-03       Impact factor: 4.379

4.  Serum Uric Acid Levels in Relation to Atrial Fibrillation: A Case-Control Study.

Authors:  Xia Zhong; Huachen Jiao; Dongsheng Zhao; Jing Teng
Journal:  Med Sci Monit       Date:  2022-02-27

5.  Evaluation of the Effect of Topiroxostat on Renal Function in Patients with Hyperuricemia: STOP-C Study, a Retrospective Observational Cohort Study.

Authors:  Eiji Tamiya; Haruyo Yamashita; Tomosato Takabe; Takahiro Matsumoto; Jun Kajihara; Shouichi Yamamoto; Tatsuji Kanoh; Hikaru Koide; Tohru Minamino
Journal:  Drugs Real World Outcomes       Date:  2022-01-29

6.  Association of Hyperuricemia with Impaired Left Ventricular Systolic Function in Patients with Atrial Fibrillation and Preserved Kidney Function: Analysis of the POL-AF Registry Cohort.

Authors:  Marcin Wełnicki; Iwona Gorczyca-Głowacka; Arkadiusz Lubas; Wiktor Wójcik; Olga Jelonek; Małgorzata Maciorowska; Beata Uziębło-Życzkowska; Maciej Wójcik; Robert Błaszczyk; Renata Rajtar-Salwa; Tomasz Tokarek; Jacek Bil; Michał Wojewódzki; Anna Szpotowicz; Małgorzata Krzciuk; Monika Gawałko; Agnieszka Kapłon-Cieślicka; Anna Tomaszuk-Kazberuk; Anna Szyszkowska; Janusz Bednarski; Elwira Bakuła-Ostalska; Beata Wożakowska-Kapłon; Artur Mamcarz
Journal:  Int J Environ Res Public Health       Date:  2022-06-14       Impact factor: 4.614

7.  Association between four nontraditional lipids and ischemic stroke: a cohort study in Shanghai, China.

Authors:  Minhua Tang; Qi Zhao; Kangqi Yi; Yiling Wu; Yu Xiang; Shuheng Cui; Xuyan Su; Yuting Yu; Genming Zhao; Yonggen Jiang
Journal:  Lipids Health Dis       Date:  2022-08-16       Impact factor: 4.315

8.  Metabolic syndrome - a new definition and management guidelines: A joint position paper by the Polish Society of Hypertension, Polish Society for the Treatment of Obesity, Polish Lipid Association, Polish Association for Study of Liver, Polish Society of Family Medicine, Polish Society of Lifestyle Medicine, Division of Prevention and Epidemiology Polish Cardiac Society, "Club 30" Polish Cardiac Society, and Division of Metabolic and Bariatric Surgery Society of Polish Surgeons.

Authors:  Piotr Dobrowolski; Aleksander Prejbisz; Alina Kuryłowicz; Alicja Baska; Paweł Burchardt; Krzysztof Chlebus; Grzegorz Dzida; Piotr Jankowski; Jerzy Jaroszewicz; Paweł Jaworski; Karol Kamiński; Agnieszka Kapłon-Cieślicka; Marek Klocek; Michał Kukla; Artur Mamcarz; Agnieszka Mastalerz-Migas; Krzysztof Narkiewicz; Lucyna Ostrowska; Daniel Śliż; Wiesław Tarnowski; Jacek Wolf; Mariusz Wyleżoł; Tomasz Zdrojewski; Maciej Banach; Andrzej Januszewicz; Paweł Bogdański
Journal:  Arch Med Sci       Date:  2022-08-30       Impact factor: 3.707

9.  Potential role of tea drinking in preventing hyperuricaemia in rats: biochemical and molecular evidence.

Authors:  Siyao Sang; Lufei Wang; Taotao Liang; Mingjie Su; Hui Li
Journal:  Chin Med       Date:  2022-09-15       Impact factor: 4.546

10.  The prevalence of MAFLD and its association with atrial fibrillation in a nationwide health check-up population in China.

Authors:  Fang Lei; Juan-Juan Qin; Xiaohui Song; Ye-Mao Liu; Ming-Ming Chen; Tao Sun; Xuewei Huang; Ke-Qiong Deng; Xiuran Zuo; Dongai Yao; Li-Juan Xu; Huiming Lu; Gang Wang; Feng Liu; Lidong Chen; Jie Luo; Jiahong Xia; Lin Wang; QiongYu Yang; Peng Zhang; Yan-Xiao Ji; Xiao-Jing Zhang; Zhi-Gang She; Qiang Zeng; Hongliang Li; Jingjing Cai
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-27       Impact factor: 6.055
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.